Jeanne Lawrence to Down Syndrome
This is a "connection" page, showing publications Jeanne Lawrence has written about Down Syndrome.
Connection Strength
3.925
-
Gupta K, Czerminski JT, Lawrence JB. Trisomy silencing by XIST: translational prospects and challenges. Hum Genet. 2024 Jul; 143(7):843-855.
Score: 0.860
-
Moon JE, Lawrence JB. Chromosome silencing in?vitro reveals trisomy 21 causes cell-autonomous deficits in angiogenesis and early dysregulation in Notch signaling. Cell Rep. 2022 08 09; 40(6):111174.
Score: 0.771
-
Czerminski JT, Lawrence JB. Silencing Trisomy 21 with XIST in Neural Stem Cells Promotes Neuronal Differentiation. Dev Cell. 2020 02 10; 52(3):294-308.e3.
Score: 0.646
-
Chiang JC, Jiang J, Newburger PE, Lawrence JB. Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro. Nat Commun. 2018 12 05; 9(1):5180.
Score: 0.597
-
Lawrence J, Telfer C. Interview: from Down's syndrome to basic epigenetics and back again. Epigenomics. 2013 Dec; 5(6):611-4.
Score: 0.422
-
Jiang J, Jing Y, Cost GJ, Chiang JC, Kolpa HJ, Cotton AM, Carone DM, Carone BR, Shivak DA, Guschin DY, Pearl JR, Rebar EJ, Byron M, Gregory PD, Brown CJ, Urnov FD, Hall LL, Lawrence JB. Translating dosage compensation to trisomy 21. Nature. 2013 Aug 15; 500(7462):296-300.
Score: 0.411
-
Condoluci C, Palmirotta R, Lawrence JB, Smith KP, Casini AR, Di Girolamo G, Majolini LA, Valente MG, Spila A, Miele C, Ferroni P, Guadagni F. Establishment of a Biorepository for Down Syndrome: Experience of the Inter-Institutional Multidisciplinary BioBank - BioBIM. Discov Med. 2024 May; 36(184):913-922.
Score: 0.217